(Q45826429)

English

A pharmacometric approach to quantify the impact of chronic kidney disease and hemodialysis on systemic drug exposure: application to saxagliptin

scientific article published in January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/22232748

A pharmacometric approach to quantify the impact of chronic kidney disease and hemodialysis on systemic drug exposure: application to saxagliptin (English)

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/22232748

1 reference

ChEBI release 2020-05-28

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

author name string

Liping Zhang

1

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/22232748

David W Boulton

2

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/22232748

Marc Pfister

3

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/22232748

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2012

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/22232748

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/22232748

52

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/22232748

1 Suppl

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/22232748

126S-33S

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/22232748

Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider

1 reference

https://api.crossref.org/works/10.1177%2F0091270011415627

21 January 2018

Drug dosing in patients with impaired renal function

1 reference

https://api.crossref.org/works/10.1177%2F0091270011415627

21 January 2018

Enoxaparin and bleeding complications: a review in patients with and without renal insufficiency

1 reference

https://api.crossref.org/works/10.1177%2F0091270011415627

21 January 2018

Comparison of loop diuretics in patients with chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1177%2F0091270011415627

21 January 2018

In-center hemodialysis six times per week versus three times per week

1 reference

https://api.crossref.org/works/10.1177%2F0091270011415627

21 January 2018

Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0091270011415627

21 January 2018

Saxagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1177%2F0091270011415627

21 January 2018

Application of Individualized Bayesian Urea Kinetic Modeling to pediatric hemodialysis

1 reference

https://api.crossref.org/works/10.1177%2F0091270011415627

21 January 2018

Emerging evidence of the impact of kidney disease on drug metabolism and transport

1 reference

https://api.crossref.org/works/10.1177%2F0091270011415627

21 January 2018

Identifiers

10.1177/0091270011415627

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/22232748

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/22232748

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45826429&oldid=2084801636"